Table 2.
The clinical and virological parameters of HBV patients.
| Patients | Age/sex | Diagnosis | Previous antiviral therapy | Liver function test | Serological markers | Serum HBV DNA (IU/ml) | ||||
|---|---|---|---|---|---|---|---|---|---|---|
| HBsAg | Anti-HBs | Anti-HBc | HBeAg | Anti-HBe | ||||||
| 1 | 40/F | Carrier | No | Normal | + | − | + | + | − | 10000000 |
| 2 | 40/M | Carrier | No | Normal | + | − | + | + | − | 4540000 |
| 3 | 41/M | Cirrhosis | No | ALT: 45U/L | + | − | + | − | + | <20 |
| 4 | 35/M | Cirrhosis | Adefovir Dipivoxil | ALT: 43.8U/L | + | − | + | + | − | <20 |
| 5 | 42/M | Cirrhosis | No | ALT: Normal; AST: 48.5U/L | + | − | + | − | + | <20 |
HBV DNA was measured by using COBAS TaqMan HBV test kits. The detection limit of HBV DNA was 20 IU/mL.